Basic info
Industry
biotechnology research
Sectors
clinical trial
Biotechnology
TCR
Oncology
lifesciences
T cells
celltherapy
NKT Cells
Health Care
CAR
Immunotherapy
Medical
CAR-NKT
Cancer
Date founded
2005
Funding rounds raised
Total raised
$78M
from 11 investors over 11 rounds
K
Kuur Therapeutics raised undisclosed on January 18, 2021
Investors: Hambro Perks
K
Kuur Therapeutics raised $73M on March 15, 2017
Investors: Invesco Perpetual, Woodford Investment Management and TOUCHSTONE INNOVATIONS PLC
K
Kuur Therapeutics raised $78M on November 25, 2014
Investors: Imperial College London and Woodford Investment Management
K
Kuur Therapeutics raised $26M on July 23, 2012
Investors: Imperial College London and Wellcome Trust
K
Kuur Therapeutics raised $7.3M on September 21, 2009
Investors: Imperial College London
K
Kuur Therapeutics raised $3.7M on March 30, 2007
Investors: Innovation and New Ventures Office and Wellcome Trust